Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of COVIVAC Vaccine in Adults in Vietnam
NCT04830800Phase 1Completed
- Sponsor
- Institute of Vaccines and Medical Biologicals
- Start
- Mar 2021
- Primary completion
- Jun 2021
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of COVI-VAC in coronavirus disease 2019 (COVID-19) (5 arms), sponsored by Institute of Vaccines and Medical Biologicals. Primary endpoints: Solicited Adverse Events, Clinical Safety Tests and 4 more. Started Mar 2021; status: completed.
02
Drugs
COVI-VAC
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04830800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04830800.